Phospholipases A2 are a family of enzymes that hydrolyze membrane phospholipids to generate free fatty acids and lysophospholipids. They are involved in a wide range of processes such as inflammation, phospholipid remodeling, cell proliferation and apoptosis. Using group V secretory PLA2 (sPLA2)-null mouse peritoneal macrophages we showed that group V sPLA2 amplifies the action of cytosolic PLA2alpha (cPLA2 alpha) in regulating eicosanoid generation after zymosan phagocytosis. Our recent study with group V sPLA2-null macrophages suggests that group V sPLA2 has a unique role in regulating phagocytosis, a function that is not shared with cPLA2alpha or group IIA sPLA2. Furthermore, our preliminary data show that group V sPLA2-null macrophages have attenuated phagocytosis of red blood cells opsonized with IgG or with complement and of Candida albicans. However, little is known regarding the mechanism/s of action of group V sPLA2 and how it regulates phagocytosis. We hypothesize that group V sPLA2 regulates the early steps of phagocytosis and that this function is related to its particular structural characteristics. Therefore in specific Aim 1 we will examine binding of phagocytic particles, phosphorylation of non-receptor tyrosine kinases, and activation of members of the Rho family of GTPases (molecules that are central to phagocytosis) in group V sPLA2-null and wild type peritoneal macrophages in response to phagocytic stimuli.
Specific Aim 2 will test the hypothesis that group V sPLA2 is critical for the immune response to specific pathogens such as Candida albicans, which triggers the same cell surface receptors as zymosan and IgG-opsonized Klebsiella pneumoniae. To this purpose we will evaluate the ability of group V sPLA2-null macrophages to phagocytose and kill Candida albicans, non opsonized and IgG-opsonized Klebsiella pneumoniae and the mechanism/s of the putative action of group V sPLA2. We will extend these studies to an in vivo model of infection with C. albicans and K. pneumoniae. Lastly, in specific Aim 3 we will examine the relationship of the structure of group V sPLA2 to its function. We will use site-directed mutagenesis and adenoviral vectors to examine phagocytosis in group V sPLA2-null macrophages reconstituted with group V sPLA2 mutants that (i) lack interfacial binding to PC, (ii) can not bind to proteoglycan, or (iii) lack catalytic activity. Relevance. Phagocytosis is the very early step in innate and acquired immune responses such as host defense against pathogens and antigen presentation. Infectious diseases are still the major cause of death in the world. Understanding how group V sPLA2 regulates phagocytosis will help to better understand the mechanisms of allergic, immunologic, and infectious diseases in which phagocytosis has a leading role, and to develop better means of preventing, diagnosing, and treating these illnesses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08AI064226-05
Application #
8072728
Study Section
Allergy & Clinical Immunology-1 (AITC)
Program Officer
Prograis, Lawrence J
Project Start
2007-07-01
Project End
2012-05-31
Budget Start
2011-06-01
Budget End
2012-05-31
Support Year
5
Fiscal Year
2011
Total Cost
$130,150
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Ohta, Shin; Imamura, Mitsuru; Xing, Wei et al. (2013) Group V secretory phospholipase A2 is involved in macrophage activation and is sufficient for macrophage effector functions in allergic pulmonary inflammation. J Immunol 190:5927-38
Giannattasio, Giorgio; Ohta, Shin; Boyce, Joshua R et al. (2011) The purinergic G protein-coupled receptor 6 inhibits effector T cell activation in allergic pulmonary inflammation. J Immunol 187:1486-95
Giannattasio, Giorgio; Fujioka, Daisuke; Xing, Wei et al. (2010) Group V secretory phospholipase A2 reveals its role in house dust mite-induced allergic pulmonary inflammation by regulation of dendritic cell function. J Immunol 185:4430-8
Simarro, Maria; Giannattasio, Giorgio; De la Fuente, Miguel A et al. (2010) Fas-activated serine/threonine phosphoprotein promotes immune-mediated pulmonary inflammation. J Immunol 184:5325-32
Boilard, Eric; Lai, Ying; Larabee, Katherine et al. (2010) A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis. EMBO Mol Med 2:172-87
Maekawa, Akiko; Balestrieri, Barbara; Austen, K Frank et al. (2009) GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4. Proc Natl Acad Sci U S A 106:11685-90
Balestrieri, Barbara; Maekawa, Akiko; Xing, Wei et al. (2009) Group V secretory phospholipase A2 modulates phagosome maturation and regulates the innate immune response against Candida albicans. J Immunol 182:4891-8